These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Commentary. Cantor T Clin Chem; 2009 Sep; 55(9):1740. PubMed ID: 19717661 [No Abstract] [Full Text] [Related]
3. The evolution of assays for parathyroid hormone. Goodman WG Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352 [TBL] [Abstract][Full Text] [Related]
4. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Meany DL; Jan de Beur SM; Bill MJ; Sokoll LJ Clin Chem; 2009 Sep; 55(9):1737-9. PubMed ID: 19717659 [No Abstract] [Full Text] [Related]
5. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. Ferreira MA Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268 [No Abstract] [Full Text] [Related]
6. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330 [No Abstract] [Full Text] [Related]
7. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure]. Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939 [TBL] [Abstract][Full Text] [Related]
8. Pth 1-84, Pth fragments and bone turnover. Malluche HH; Monier-Faugere MC Am J Kidney Dis; 2003 May; 41(5):1127. PubMed ID: 12722056 [No Abstract] [Full Text] [Related]
9. Assays for parathyroid hormone and their use in patients with end-stage renal disease. Goodman WG Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757 [TBL] [Abstract][Full Text] [Related]
10. Target levels for serum phosphorus and parathyroid hormone. Qunibi W; Kalantar-Zadeh K Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001 [No Abstract] [Full Text] [Related]
11. Biological markers in the diagnosis of the different forms of renal osteodystrophy. Ferreira A; Drüeke TB Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481 [TBL] [Abstract][Full Text] [Related]
12. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Fournier A; Ghitu S; Bako G; Ben Amar L; Oprisiu R; Hottelart C; Cohen Solal ME Nephrol Dial Transplant; 1999 Nov; 14(11):2772-4. PubMed ID: 10534531 [No Abstract] [Full Text] [Related]
13. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856 [TBL] [Abstract][Full Text] [Related]
14. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients]. Goto S; Fukagawa M Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657 [TBL] [Abstract][Full Text] [Related]
15. Managing bone mineral disorders in CKD: an overview of current therapies. Delaney M J Ren Care; 2009 Mar; 35 Suppl 1():107-10. PubMed ID: 19222741 [No Abstract] [Full Text] [Related]
16. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure]. Ziółkowska H; Roszkowska-Blaim M Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516 [TBL] [Abstract][Full Text] [Related]
17. Bone biopsy in chronic kidney disease: still an option? Drueke TB J Bras Nefrol; 2020 May; 42(2):130-132. PubMed ID: 32459283 [No Abstract] [Full Text] [Related]
18. Renal osteodystrophy in children with end-stage kidney failure. Chan JC Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255 [TBL] [Abstract][Full Text] [Related]
19. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Reichel H; Esser A; Roth HJ; Schmidt-Gayk H Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646 [TBL] [Abstract][Full Text] [Related]